Search Results 651-660 of 13355 for Birth Control Palette

  1. A Study to Evaluate Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin-Angiotensin Aldosterone System Inhibitor (RAASi) Medications for the Treatment of Heart Failure (DIAMOND) - Mayo Clinic

    Females of child-bearing potential must be non-lactating, must have a negative pregnancy test at Screening, and must agree to continue using contraception ...

  2. The International Diabetes Closed Loop (iDCL) Trial: Protocol 1 - Mayo Clinic

    The objective of the study is to assess the efficacy and safety of home use of a Control-to-Range (CTR) closed-loop (CL) system. Participation eligibility.

  3. Study of Pembrolizumab With Ipilimumab or Placebo in Participants with Untreated Metastatic Non-small Cell Lung Cancer - Mayo Clinic

    ... contraceptive guidance during the treatment ... Note: As of amendment 06, contraception is no longer required for male participants. ... Subjects who use inhaled ...

  4. An Extension Study Of Subjects Who Received An Avalyn Inhaled Antifibrotic Agent (SAIL) - Mayo Clinic

    * Male subjects and female subjects of childbearing potential (FOCBP) agree to use highly effective contraception measures from the time of first dose of ...

  5. A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4) - Mayo Clinic

    Abstinent or willing to use adequate contraception from Screening through the week 24 visit. Males (as assigned at birth) must fulfill the following criteria:.

  6. A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    ... contraception throughout the treatment period and for 6 months after discontinuing study treatment. ... Chronic graft versus host disease (GVHD) or on ...

  7. Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH - Mayo Clinic

    All sexually active female subjects of childbearing potential must agree to use a protocol recommended method of contraception during heterosexual ...

  8. Chemotherapy - Mayo Clinic

    Chemotherapy is often used to prepare for a bone marrow transplant. Immune system disorders. Lower doses of chemotherapy drugs can help control an overactive ...

  9. Study of Ociperlimab in Combination With Tislelizumab in Advanced Solid Tumors - Mayo Clinic

    PD-L1 positive. 4. ECOG Performance Status ≤ 1 5. Adequate organ function 6. Willing to use highly effective method of birth control. Phase 1 Key Exclusion ...

  10. Acceptability Of Testing DNA Markers In Vaginal Fluid For The Detection Of Endometrial Cancer - Mayo Clinic

    Assigned female sex at birth. Willing to participate in a 30-minute virtual interview. Exclusion Criteria: Previous or current diagnosis of endometrial ...